Home > Healthcare > Medical Devices > Surgical Devices > Heart Closure Devices Market

Heart Closure Devices Market Size

  • Report ID: GMI6140
  • Published Date: Jul 2023
  • Report Format: PDF

Heart Closure Devices Market Size

Heart Closure Devices Market size was valued at USD 2.2 billion in 2022 and is estimated to witness 12.2% CAGR from 2023 to 2032, attributed to the various factors comprising the increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, rising demand for transcatheter interventions, etc. The rising incidence of cardiovascular diseases, such as coronary artery disease and structural heart defects, is expected to drive the demand for heart closure devices. This trend is fuelled by factors comprising sedentary lifestyles, unhealthy diets, and an aging population.

 

Minimally invasive procedures are gaining popularity due to their advantages over traditional open-heart surgeries. Heart closure devices play a crucial role in these procedures by providing efficient and effective closure of structural defects or access sites, reducing the need for large incisions, and promoting faster recovery times for patients. Similarly, the heart closure devices market is expanding in emerging economies due to improving healthcare infrastructure, rising healthcare awareness, and increasing affordability. These variables offer significant growth opportunities for companies involved in manufacturing and distributing heart closure devices.

Heart closure devices, also known as occluders or septal occluders, are medical devices used to close abnormal openings in the heart, particularly atrial or ventricular septal defects. These defects are congenital conditions where there are abnormal openings between the chambers of the heart, allowing blood to flow in unintended directions.
 

However, the potential complications and adverse events related to heart closure devices may hamper the heart closure devices market growth. These can include device dislodgement, migration, fracture, or embolization. These complications may require additional interventions or surgery to retrieve or reposition the device. In some cases, blood clots may form on the surface of the device or in the area surrounding it. These clots can potentially lead to stroke, heart attack, or other ischemic events if they dislodge and travel to other parts of the body. Some individuals may experience allergic reactions to the materials used in heart closure devices, particularly if they have a known allergy to certain metals or other components.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of heart closure devices was reached USD 2.2 billion in 2022 and is estimated to be worth more than USD 6.6 billion by 2032, due to the growing prevalence of cardiovascular diseases and higher adoption of minimally invasive procedures.

The left atrial appendage (LAA) closure devices product segment is projected to generate more than USD 2.9 billion by 2032, owing to several advantages associated with these devices in the heart closure treatment procedures.

U.S. market is estimated to expand at a notable pace and amass more than USD 2.7 billion by 2032 driven by the strong presence of major industry players, scaling demand for heart closure procedures, and the high prevalence of cardiovascular conditions.

Some of the top companies operating in the industry are Abbott Laboratories, AtriCure Inc., Biosense Webster, Inc., Boston Scientific Corporation, and Cardia, Inc.

Heart Closure Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 452
  • Countries covered: 30
  • Pages: 180
 Download Free Sample